The Administrative Core (AC) provides oversight of all scientific and fiscal aspects of the PPG as well as management of all collaborative activities and coordinating. It will coordinate and organize the meetings of the projects and cores leaders and staff. The core will also organize and facilitate meetings of the Internal and External Advisory Committees. The AC will be responsible for the implementation of decisions, corrective actions, suggestions, and initiatives recommended by the Advisory Committees as well as the project leaders. The AC will provide tools and platforms that will foster the integration, collaboration, and communication within the program. The core will be responsible for all interactions with University of Colorado central resources as well as other institutions involved in this project including the University of Colorado Hospital, National Jewish Hospital, and Stanford University.

Public Health Relevance

Contact PD/PI: Stenmark, Kurt, R. At the 2013 World Symposium on Pulmonary Hypertension, inflammation was identified as one of the key pathogenic features of pulmonary hypertension (PH). Investigators in this program have played key roles in identifying the potential role of inflammatory cells in the vascular remodeling process that characterizes all chronic forms of PH. This program addresses in three highly integrated and mechanistic projects the role of inflammation, and more specifically the role of macrophages in the vascular remodeling that characterizes the most frequent forms of PH. Through the scope of the projects and the overall infrastructure (three supporting scientific core laboratories), we are poised to provide novel insights into the complex cellular and molecular topophysiology of inflammation in various forms of PH, hopefully leading to identification of translatable new therapeutic approaches for human forms of the disease. Project Narrative Page 190

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL014985-44
Application #
9505961
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Fessel, Joshua P
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Das, Mita; Zawada, W Michael; West, James et al. (2018) JNK2 regulates vascular remodeling in pulmonary hypertension. Pulm Circ 8:2045894018778156
Tamosiuniene, Rasa; Manouvakhova, Olga; Mesange, Paul et al. (2018) Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension. Circ Res 122:1689-1702
Blum, Lisa K; Cao, Richard R L; Sweatt, Andrew J et al. (2018) Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension. Eur J Immunol 48:874-884
Kumar, Rahul; Graham, Brian (2018) IL-33-HIF1? Axis in Hypoxic Pulmonary Hypertension. EBioMedicine 33:8-9
Ding, Yonghui; Xu, Xin; Sharma, Sadhana et al. (2018) Biomimetic soft fibrous hydrogels for contractile and pharmacologically responsive smooth muscle. Acta Biomater 74:121-130
Kumar, Rahul; Graham, Brian (2018) How does inflammation contribute to pulmonary hypertension? Eur Respir J 51:
Jiang, Xinguo; Nicolls, Mark R; Tian, Wen et al. (2018) Lymphatic Dysfunction, Leukotrienes, and Lymphedema. Annu Rev Physiol 80:49-70
Schäfer, Michal; Humphries, Stephen; Stenmark, Kurt R et al. (2018) 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Imaging 19:415-424
D'Alessandro, Angelo; El Kasmi, Karim C; Plecitá-Hlavatá, Lydie et al. (2018) Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming. Antioxid Redox Signal 28:230-250
Karoor, Vijaya; Fini, Mehdi A; Loomis, Zoe et al. (2018) Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice. Arterioscler Thromb Vasc Biol 38:154-163

Showing the most recent 10 out of 148 publications